Apellis Pharmaceuticals Inc Strategic Asset Allocation Index
Apellis Pharmaceuticals Inc strategic asset allocation index. Apellis Pharmaceuticals Inc (APLS) has a Strategic Asset Allocation Index of 14.7% as of December 2022. Strategic assets (PP&E of $24.89 Million plus long-term investments of $-) total $24.89 Million, measured against net assets of $169.87 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See Apellis Pharmaceuticals Inc balance sheet independence to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Strategic Asset Allocation Index of Apellis Pharmaceuticals Inc (2014–2022)
Strategic asset allocation index of Apellis Pharmaceuticals Inc from 2014 to 2022. This chart shows how Apellis Pharmaceuticals Inc's Strategic Asset Allocation Index has evolved across 6 annual periods from 2014 to 2022. As of December 2022, the index stands at 14.7%, representing strategic assets of $24.89 Million against net assets of $169.87 Million USD. Check APLS tangible net worth ratio to evaluate the tangible quality of the company's equity base.
Apellis Pharmaceuticals Inc Strategic Asset Allocation Index by Year (2014–2022)
Apellis Pharmaceuticals Inc strategic asset allocation index by year from 2014 to 2022. The table below presents the year-by-year Strategic Asset Allocation Index for Apellis Pharmaceuticals Inc from 2014 to 2022, covering 6 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see market value of Apellis Pharmaceuticals Inc.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 14.7% | $24.89 Million | $24.89 Million | $- | $169.87 Million | ▲ +1.5 pp |
| 2021 | 13.1% | $26.08 Million | $26.08 Million | $- | $198.66 Million | ▲ +1.1 pp |
| 2020 | 12.0% | $24.52 Million | $24.52 Million | $- | $204.56 Million | ▼ -34.1 pp |
| 2019 | 46.1% | $15.77 Million | $15.77 Million | $- | $34.23 Million | ▲ +45.4 pp |
| 2018 | 0.6% | $977.92K | $977.92K | $- | $160.97 Million | ▲ +0.4 pp |
| 2014 | 0.2% | $21.68K | $21.68K | $- | $13.22 Million | — |